HLL to launch urine based fertility measuring kits first time in India


Trivandrum: With over 30 million infertile couples in the country and numbers still swelling rapidly, HLL Lifecare Ltd., one of the largest manufacturers of contraceptives and allied products in the world, is launching first-of-its-kind simple and cost-effective urine-based fertility measuring kits. The Indian Council of Medical Research (ICMR) has recently transferred this technology developed by National Institute for Research in Reproductive Health (NIRRH) to HLL Lifecare for validation, commercialisation and marketing of the test kits.

Compared to the existing special procedures which are expensive, time consuming and stressful, the urine-based kit would have four simple and cost-effective technology based on enzyme linked immune-sorbent assay (ELISA). The technology was developed by Dr. M I Khatkhatay and Dr. Meena Desai of NIRRH, an institution of the ICMR, in a project funded by Department of Biotechnology (DBT), Govt. of India and the technology transfer was done by Biotech Consortium India Ltd. (BCIL), a technical arm of DBT.

A tri-partite technology transfer agreement was signed recently by Dr. K R S Krishnan, Head – R&D, HLL with Dr. Poornima Sharma, CEO, BCIL and Dr. Sanjiva D Kholkute, Director, NIRRH in the presence of Dr. V M Katoch, Secretary, Department of Health Research & Director General, ICMR at ICMR Headquarters, New Delhi.

Dr Katoch said, “It is essential that fruits of public-funded research should reach the society in an affordable manner. Being a central PSU under the Health Ministry, HLL is well equipped for such a mission. That makes the technology transfer agreement more meaningful.”

M Ayyappan, CMD, HLL said, “HLL  has always been in the forefront to offer affordable and accessible reproductive healthcare solutions for the people around the globe and Urine based fertility kit is part of our endeavour towards this. I hope that this new discovery will put many people who are at risk of infertility at ease”.

The kit will be commercially available in the market within 24 months. The technology transfer involves global exclusive and perpetuating rights for manufacture, marketing and sale of kit. Under the agreement, the HLL will take up mass production and marketing of the urine-based fertility test kit for measurement of four key reproductive hormones of four principal metabolites.

Kerala Biz News


Comments are closed.